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Host genetics shapes adult sepsis survival
Sepsis is a major cause of death in adult intensive-care 
units (ICUs) worldwide,1 despite the availability of a few 
highly eﬀ ective therapeutic procedures. This syndrome 
develops as a result of a suspected or proven severe 
infection by diﬀ erent microorganisms (most commonly 
established intra-abdominally or in the lungs) and is 
characterised by a dysregulated non-speciﬁ c acute 
inﬂ ammatory response, frequently leading to multiple 
organ failure. 
The innate immunity responsiveness to an infection 
or to microbial products is shaped by the genetic 
diﬀ erences between individuals, emphasising the 
crucial role of the host defence in the pathophysiology 
of this complex syndrome.2,3 Such genetic diﬀ erences 
could explain the diversity of clinical manifestations 
between patients with sepsis, and ultimately aﬀ ect 
the mortality risk. One of the ﬁ rst ﬁ ndings supporting 
this possibility was obtained from epidemiological 
studies of adoption, in which adoptees showed an 
increased risk of death due to infections when one 
of their biological parents had died from infections.4 
Other studies in twins and siblings have supported this 
early ﬁ nding, also revealing rather weak eﬀ ects of host 
genetics on susceptibility to infections.5
Genetic studies have suggested that natural 
variants located in or nearby the genes encoding 
components of the pathogen-sensing machinery 
are associated with sepsis outcomes2 and with 
sustained pro-inﬂ ammation after the setting of 
sepsis.6 However, most, if not all, genetic factors that 
have been implicated so far in sepsis susceptibility 
or outcomes were found with limited screens of the 
genetic variation in candidates with the popular case-
control study design. Despite the large number of such 
studies, re-analyses of the accumulated evidence did 
not show ﬁ rmly associated genes.7 
Genome-wide association studies (GWAS) are 
built on the same screening idea on a genomic 
scale, providing a reasonably unbiased method to 
ﬁ nd genetic risk factors for disease.8 In The Lancet 
Respiratory Medicine, Anna Rautanen and colleagues9 
present the results from the ﬁ rst GWAS on survival 
from sepsis due to pneumonia, assessed in a multi-
stage study including four cohorts and testing 
almost 6 million single nucleotide polymorphisms 
(SNPs). Using 28 day survival as a binary observation, 
the investigators identiﬁ ed SNPs from 11 loci with 
suggestive genome-wide signiﬁ cance in the discovery 
stage. Only one C/T SNP in chromosome 5, residing 
within the FER gene, showed consistent eﬀ ects across 
the four cohort studies analysed. The C allele, with 
nearly 20% frequency in European populations, was 
associated with reduced mortality by sepsis caused by 
pneumonia with an unusually strong eﬀ ect compared 
with those reported for genetic risks in other complex 
traits.8 Importantly, the acute respiratory distress 
syndrome, a common sepsis-associated complication, 
was not a confounding factor for the observed eﬀ ect. 
The identiﬁ ed SNP in FER is intronic and has no evident 
functional consequences on the gene, as judging by the 
RegulomeDB and HaploReg. However, this situation 
is very common at the moment, since about 80% 
of identiﬁ ed risk variants in the published GWAS in 
complex diseases reside in intergenic or non-coding 
intronic regions.8 Although the work by Rautanen and 
colleagues9 did not provide a functional assessment 
of the top associated SNP, limiting a straightforward 
translation to the mechanism of disease, FER gene 
encodes a ubiquitously expressed non-transmembrane 
receptor tyrosine kinase. Since this kinase mediates in 
the actomyosin contractile machinery via growth factor 
receptors, regulating cell-cell adhesion and mediating 
neutrophil chemotaxis, its eﬀ ects could be related to 
the host defense against pathogens or endothelial 
permeability. Since the identiﬁ ed SNP, or even the FER 
gene, might not be causally related to sepsis survival, 
further studies will be needed to address this point, as the 
genetic variation explored in the study only constitute 
a fraction of the real genetic diversity. Both, extensive 
sequencing of this genomic region to unravel unknown 
low-frequency variants with potential biological roles, 
and mechanistic understanding of the risk variants 
identiﬁ ed, will permit delineating the most likely causal 
variants. Additionally, in view of the reported ethnic 
disparities in sepsis incidence and mortality,10 similar 
studies in samples of diverse geographical origin should 
be pursued to verify whether the FER SNP eﬀ ect also 
pertains to sepsis survival in other populations.
Personalised medicine is based on the idea that if 
enough informative risk factors are known, more 
For RegulomeDB see http://
regulomedb.org
For HaploReg see http://www.
broadinstitute.org/mammals/
haploreg/haploreg_v3.php
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Over the past 30 years, non-invasive ventilation (NIV) 
has revolutionised the care of patients with acute and 
acute-on-chronic respiratory failure, and is now thought 
of as the standard of care. Improvements in survival 
and intubation rates are well established.1 However, 
uncertainty remains as to whether NIV relieves subjective 
dyspnoea.2 Whereas some patients adapt readily, others 
struggle. Development of a sound understanding of 
subjective experience for NIV might decrease intolerance 
and accelerate improvements in care.
Patient-centred care is increasingly recommended in 
policy, practice, and research.3 Clinicians who understand 
the patient’s experience are well placed to balance the 
potentially competing pressures of clinical indications and 
the comfort and preference of the patient. In interventions 
for which patient cooperation is crucial, such as NIV, this 
balance is essential. Despite this need for cooperation, little 
is known about what is happening behind the mask.
Two qualitative studies4,5 from Scandinavian nurse-led 
research teams have analysed the behaviours adopted by 
patients adjusting to acute NIV. Both studies reported on 
patients with acute exacerbations of chronic obstructive 
pulmonary disease. Torheim and colleagues4 analysed 
in-depth interviews with ﬁ ve patients who had recently 
received NIV, and noted that patients reported initial 
feelings of being trapped and completely dependent 
on others. Reports from patients suggested that 
skilled nursing assistance and mobilisation of internal 
resources, including willpower, helped them to gain 
control over their treatment and increase their tolerance 
of NIV.4 Although this investigation is an important 
exploratory study, no attempt was made to reach 
thematic saturation (the point at which no additional 
themes are identiﬁ ed from the reviewing of successive 
data), which is a potential methodological limitation. 
Sørenson and colleagues5 studied 21 patients 
undergoing NIV and undertook 11 in-depth patient 
interviews to develop a behavioural model of the 
experience of treatment with NIV. This group also saw 
an initial phase in which patients felt restrained by the 
Life behind the mask: the patient experience of NIV 
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Many risk variants for sepsis survival await their 
discovery since the study by Rautanen and colleagues9 
was underpowered to detect all but the loci with 
the largest eﬀ ects. Therefore, in view of our limited 
knowledge of the genes that contribute to shape the 
diﬀ erences in sepsis survival between patients, and 
the poor prognostic utility of the identiﬁ ed FER genetic 
variant, this possibility is remote for now. To increase 
the power to detect additional risk variants underlying 
the diversity of sepsis manifestations, further genetic 
studies should focus on particular infections (source 
or causal pathogen), rather than on a broadly deﬁ ned 
syndrome, and on speciﬁ c traits related to severity and 
outcomes. 
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